0000831547-22-000036.txt : 20220517 0000831547-22-000036.hdr.sgml : 20220517 20220517162110 ACCESSION NUMBER: 0000831547-22-000036 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20220504 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20220517 DATE AS OF CHANGE: 20220517 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SPECTRUM PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000831547 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930979187 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-35006 FILM NUMBER: 22934794 BUSINESS ADDRESS: STREET 1: 11500 S. EASTERN AVE., SUITE 240 CITY: HENDERSON STATE: NV ZIP: 89052 BUSINESS PHONE: 702-835-6300 MAIL ADDRESS: STREET 1: 11500 S. EASTERN AVE., SUITE 240 CITY: HENDERSON STATE: NV ZIP: 89052 FORMER COMPANY: FORMER CONFORMED NAME: NEOTHERAPEUTICS INC DATE OF NAME CHANGE: 19960819 FORMER COMPANY: FORMER CONFORMED NAME: AMERICUS FUNDING CORP DATE OF NAME CHANGE: 19920703 8-K/A 1 sppi-20220504.htm 8-K/A sppi-20220504
false000083154700008315472022-05-172022-05-17

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
_______________
FORM 8-K/A
(Amendment No. 1)
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 4, 2022
SPECTRUM PHARMACEUTICALS INC
(Exact name of registrant as specified in its charter)
Delaware001-3500693-0979187
(State or other jurisdiction
of incorporation)		(Commission
File Number)		(IRS Employer
Identification No.)
11500 South Eastern AvenueSuite 220HendersonNevada89052
(Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code: (702) 835-6300
Not Applicable
(Former name or former address if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.001 par valueSPPIThe NASDAQ Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


Explanatory Note
    This Amendment No. 1 on Form 8-K/A (the “Amendment”) is being filed by Spectrum Pharmaceuticals, Inc. (the “Company”) to amend the Current Report on Form 8-K filed by the Company with the Securities and Exchange Commission on May 5, 2022 (the “Original Report”), solely to supplement Item 5.02 of the Original Report to include additional disclosure regarding a board committee assignment. This Amendment does not otherwise amend, update or change any other disclosure contained in the Original Report.

Item 5.02    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

    As previously reported in the Original Report, on May 4, 2022, the Board of Directors (the “Board”) of the Company appointed Ms. Brittany K. Bradrick to serve as a member of the Board, effective immediately. On May 16, 2022, Ms. Bradrick was appointed Chairperson of the Audit Committee of the Board, effective as of May 25, 2022.


SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

SPECTRUM PHARMACEUTICALS, INC.
Date:May 17, 2022By:/s/ Keith M. McGahan
Keith M. McGahan
Executive Vice President, Chief Legal Officer and Secretary


 EX-101.SCH 2 sppi-20220504.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 sppi-20220504_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Document Type Document Type Entity Address, Postal Zip Code Entity Address, Postal Zip Code Local Phone Number Local Phone Number Amendment Flag Amendment Flag Written Communications Written Communications City Area Code City Area Code Title of 12(b) Security Title of 12(b) Security Entity Address, State or Province Entity Address, State or Province Security Exchange Name Security Exchange Name Soliciting Material Soliciting Material Document Period End Date Document Period End Date Entity Address, City or Town Entity Address, City or Town Entity Tax Identification Number Entity Tax Identification Number Cover page. Cover [Abstract] Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Pre-commencement Tender Offer Pre-commencement Tender Offer Entity Address, Address Line One Entity Address, Address Line One Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, Address Line Two Entity Address, Address Line Two Entity Emerging Growth Company Entity Emerging Growth Company Entity Registrant Name Entity Registrant Name Entity File Number Entity File Number Entity Central Index Key Entity Central Index Key Trading Symbol Trading Symbol EX-101.PRE 4 sppi-20220504_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 5 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Cover Page
May 17, 2022
Cover [Abstract]  
Document Type 8-K/A
Document Period End Date May 04, 2022
Entity Registrant Name SPECTRUM PHARMACEUTICALS INC
Entity Incorporation, State or Country Code DE
Entity File Number 001-35006
Entity Tax Identification Number 93-0979187
Entity Address, Address Line One 11500 South Eastern Avenue
Entity Address, Address Line Two Suite 220
Entity Address, City or Town Henderson
Entity Address, State or Province NV
Entity Address, Postal Zip Code 89052
City Area Code 702
Local Phone Number 835-6300
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.001 par value
Trading Symbol SPPI
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Amendment Flag false
Entity Central Index Key 0000831547
XML 6 sppi-20220504_htm.xml IDEA: XBRL DOCUMENT 0000831547 2022-05-17 2022-05-17 false 0000831547 8-K/A 2022-05-04 SPECTRUM PHARMACEUTICALS INC DE 001-35006 93-0979187 11500 South Eastern Avenue Suite 220 Henderson NV 89052 702 835-6300 false false false false Common Stock, $0.001 par value SPPI NASDAQ false EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 1 23 1 false 0 0 false 0 false false R1.htm 0001001 - Document - Cover Page Sheet http://www.sppirx.com/role/CoverPage Cover Page Cover 1 false false All Reports Book All Reports sppi-20220504.htm sppi-20220504.xsd sppi-20220504_lab.xml sppi-20220504_pre.xml http://xbrl.sec.gov/dei/2020-01-31 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "sppi-20220504.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "sppi-20220504.htm" ] }, "labelLink": { "local": [ "sppi-20220504_lab.xml" ] }, "presentationLink": { "local": [ "sppi-20220504_pre.xml" ] }, "schema": { "local": [ "sppi-20220504.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2020-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "sppi", "nsuri": "http://www.sppirx.com/20220504", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "sppi-20220504.htm", "contextRef": "i6f160993d43f442f88db23cfc60bc7ad_D20220517-20220517", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover Page", "role": "http://www.sppirx.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "sppi-20220504.htm", "contextRef": "i6f160993d43f442f88db23cfc60bc7ad_D20220517-20220517", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.sppirx.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.sppirx.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.sppirx.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.sppirx.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.sppirx.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.sppirx.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.sppirx.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.sppirx.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.sppirx.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.sppirx.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.sppirx.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.sppirx.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.sppirx.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.sppirx.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.sppirx.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.sppirx.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.sppirx.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.sppirx.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.sppirx.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.sppirx.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.sppirx.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.sppirx.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.sppirx.com/role/CoverPage" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 13 0000831547-22-000036-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000831547-22-000036-xbrl.zip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end